femhrt Cost Without Insurance: What You’ll Actually Pay in 2026

Brand-name femhrt is no longer marketed in the U.S., but FDA-approved generic versions remain available. On August 1, 2026, SingleCare displayed $25.76–$44.52 with a discount card and $46.20–$84.56 at retail for 28 tablets of the 1 mg/5 mcg generic. Cost Plus Drugs published a medication-only price working out to about $9.53 per 28 days.

Here’s the part nobody tells you. At one of those four pharmacies, the discount card cut the price by 66%. At another, it cut it by 3.6%.

Same drug. Same published table. Same card.

We’ll show you which was which — and why it matters more than any coupon code you’ll find today.

How much does femhrt cost without insurance in 2026?

Is this you?

The HRT Indexis the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

Is femhrt discontinued?

Yes. The FDA withdrew approval of femhrt (NDA 021065) effective October 5, 2023. The sponsor — Allergan Pharmaceuticals International Limited, care of AbbVie — notified the FDA in writing that the product was no longer marketed and asked the agency to withdraw the approval. The withdrawal covered both strengths: 0.0025 mg/0.5 mg and 0.005 mg/1 mg.

We read the notice ourselves. It’s in the Federal Register, Volume 88, Number 170, pages 60690–60691, published September 5, 2023 (Docket No. FDA-2023-N-3549). femhrt appears in a table of 35 applicant-requested withdrawals, alongside drugs like Pravachol, Ultram, and Niaspan.

Three things in the record matter to you, and almost nobody explains them:

1. This was not a safety withdrawal.The 2023 notice tells you the sponsor asked for it after reporting the product was no longer marketed. But the notice by itself doesn’t settle the safety question — a separate FDA record does. The FDA has issued determinations that the femhrt reference products were not withdrawn from sale for reasons of safety or effectiveness.That ’s the finding that matters, and it’s not a technicality: it’s the exact determination that allows the FDA to keep approving the generic versions you can still fill today. If the agency had found a safety problem, it would have started proceedings to pull those generics too.

2. The withdrawal was made “without prejudice to refiling.” That’s the FDA’s own language in the notice. It means the withdrawal doesn ’t block a future application. It does not mean femhrt is coming back, and we ’re not suggesting it will.

3. Pharmacies were allowed to keep selling what they already had.The notice says products in inventory on October 5, 2023 “may continue to be dispensed until the inventories have been depleted or the drug products have reached their expiration dates.”

That third point is why this got so confusing. femhrt didn’t vanish overnight. It drained out of the supply chain slowly, pharmacy by pharmacy, however long each one’s stock lasted. Price databases kept their listings. Search results kept their pages. And in 2026 you can still find major health sites listing femhrt as a current option.

It isn’t one. But the medicine you were taking is still made — just wearing a different label.

What “discontinued” does not mean

• It does not mean this combination of hormones is gone. FDA-approved generics are still marketed.
• It does not mean you should hunt down old stock. Don’t.
• It does not mean you should change or stop anything on your own. That’s a conversation with your prescriber or pharmacist.
• It does not mean every pharmacy has a generic in stock today. Stock varies. Call and ask.

→ See the current generic names, strengths, and tablet imprints

The right medication isn’t the same for every woman

Current generic prices by pharmacy and quantity

FDA-approved generic versions of the femhrt prescription were published across a wide range on August 1, 2026: about $9.53 per 28 days from a direct-cash pharmacy (medication only, before shipping), $25.76–$44.52 for 28 tablets with a discount card at four major chains, and $46.20–$84.56 at retail benchmarks for those same chains. Larger fills generally cost less per 28 days.

Every figure below has been converted to the same unit — one 28-day supply at one tablet daily— so you can actually compare them.

The 1 mg/5 mcg generic

The 0.5 mg/2.5 mcg generic

All figures captured August 1, 2026 from the named published source. We converted larger fills using: total ÷ tablets × 28. None of these was confirmed by a purchase or a phone call to a pharmacy.

We keep the two strengths in separate tables on purpose.Which strength you take is a clinical decision your prescriber already made. It’s not a shopping choice, and we won’t lay these out in a way that tempts you to switch to whichever looks cheaper.

What counts as a “real” price

Not all numbers are equal. From most reliable to least:

1. A final total your pharmacist confirms out loud, for your exact prescription, today
2. A completed checkout total at a direct-cash pharmacy, shipping included
3. A current discount-card quote for that exact strength, quantity, and pharmacy
4. A published medication-only price with shipping still to be added
5. A recent aggregate benchmark, like the retail columns above
6. A headline “as low as” number with no pharmacy, ZIP, or quantity attached
7. A legacy listing for a product that’s no longer marketed

Most pages you’ll land on are showing you number 6 or number 7 and calling it the price.

How much does Fyavolv cost without insurance?

Fyavolv is Lupin’s FDA-approved generic version, marketed in both strengths. On August 1, 2026, SingleCare’s Fyavolv page displayed a retail figure as high as $81.71 for 28 tablets of the 1 mg/5 mcg strength and a card price of $29.53 on refills. Cost Plus Drugs lists a 90-tablet pack of the same generic — $30.63 for the 1 mg/5 mcg and $29.15 for the 0.5 mg/2.5 mcg, medication only, before shipping.

If you were handed a box marked Fyavolv, price it under that name andunder the plain chemical name. They’re often listed separately, at different prices, on the same site.

How much does Jinteli cost without insurance?

Jinteli is Teva’s FDA-approved generic in the 1 mg/5 mcg strength. On August 1, 2026, SingleCare’s Jinteli page displayed an average around $90.16 for 28 tablets and a lowest displayed price of $29.46 — which includes a one-time $3 signup credit, so the recurring refill price is about $3 higher. Drugs.com displayed a 90-tablet cash listing at $83.01, or roughly $25.83 per 28 days.

Same active ingredients as Fyavolv, same strength — different company, different tablet, sometimes a different price on the same day.

What we can’t do for you

We’ll be straight with you: we can’t give you one femhrt price, and any page that hands you a single confident number is guessing.

Look at the tables again. The same medicine, on the same day, ran from about $9.53 per 28 days at a direct-cash pharmacy to $84.56 at a retail counter. That’s close to a nine-fold spread. There is no national price. There’s no “average” that would help you plan. If you came here wanting one number, we don’t have it — and neither does anyone else. They just haven’t told you.

If you genuinely need one predictable number every month, a direct-cash pharmacy with a posted price is your best shot — skip to where to fill it. Or start with our full HRT cost guide, which covers care fees too.

But here’s why that spread is good news.

Every one of those rows is an FDA-approved product with the same active ingredients, the same strength, and the same dosage form. The difference isn’t the medicine. It’s which counter and which payment route— and both of those are things you control, today, for free, without asking anyone’s permission.

Knowing which lever you’re standing on beats knowing what one stranger paid once. So let’s go through the levers.

Why does the same coupon save 66% at one pharmacy and 4% at another?

Because discount cards negotiate separately with each pharmacy chain, the savings are wildly uneven — and “just use a coupon” turns out to be weak advice at some pharmacies. In SingleCare’s own four-pharmacy table on August 1, 2026, the card cut CVS’s retail benchmark by about 66% and Walmart’s by about 3.6%.

We ran the math on their published numbers. Here it is:

The HRT Index’s arithmetic, using SingleCare’s published August 1, 2026 figures. Median individual saving: $45.61, or about 55.6%. These are published benchmarks, not confirmed counter transactions.

Read the Walmart row again. The card moved the price by $1.68.

Now look at what that row is really telling you. Walmart had the lowest retail benchmark of the four— $46.20, about $30 below CVS. Its card barely improved on it. Meanwhile CVS started $30 higher and ended up the cheapest of all four once the card was applied.

So the pharmacy with the best sticker price was the worst deal, and the pharmacy with the worst sticker price was the best one. You could not have guessed that from the outside. Neither could we, until we put both columns next to each other.

The takeaway isn’t “use a coupon.” It’s get both numbers at the same counter.

Ask the pharmacist for the plain cash price and have them run a discount card, then pick the lower one. It costs you one extra sentence. In this table, the largest gap between the two was $50.12 per 28-day fill — about $651.56 across 13 fills covering 364 days.

What a discount card actually is

It isn’t insurance. It’s a cash transaction processed through a discount network instead of your health plan. A few things follow:

• You generally can’t combine it with insurance. It’s one or the other.
• The pharmacist needs four things off the card: BIN, PCN, Group number, and Member ID.
• The online price is an estimate. Discount sites say so themselves.
• A cash purchase may not count toward your deductible or out-of-pocket maximum. If you’re close to either, ask your plan whether a cash transaction can be submitted for credit. Don’t assume it will.

Why do some sites say femhrt costs $836?

Because that listing is for 140 tablets of the no-longer-marketed brand — five 28-tablet cards at once. Drugs.com lists brand femhrt 0.5 mg/2.5 mcg at $835.59 for 140 tablets, which works out to about $167.12 per 28 days. It is a legacy listing for a product that is no longer marketed, not a benchmark for a fill you can get today.

This is the most alarming number in the search results and the least useful one. Here’s the honest comparison:

Against the 28-tablet card range, the legacy listing is roughly 3.8 to 6.5 times higherper 28 days. Against the direct-cash medication price, the gap is far wider still — though that one needs shipping added before it’s a fair fight.

If a page shows you a three-figure femhrt price without mentioning that the brand was withdrawn in 2023, you’re looking at a legacy database entry. Don’t plan around it.

Is this the same thing as birth control? Why do some listings say $12?

No. femhrt and its generics contain norethindrone acetate and ethinyl estradiol at menopause doses — 5 or 2.5 micrograms of ethinyl estradiol. The Junel, Larin, Microgestin, and Loestrin 1/20 and 1.5/30 formulations contain the same two ingredients at 20 or 30 micrograms of ethinyl estradiol and are approved to prevent pregnancy, not to treat menopause symptoms. Some very low prices listed under this ingredient pair are contraceptive formulations.

This is the trap we’re most worried about, and the major price pages we reviewed didn’t put a warning about it anywhere near their price comparisons.

Ethinyl estradiolis a lab-made estrogen — the estrogen used in combined birth control pills, measured in micrograms (thousandths of a milligram). Norethindrone acetate is a synthetic progestin, a hormone that acts on the same receptors as progesterone. Put them together and you get very different products depending on the labeled dose:

Against the lower menopause strength, that 1.5/30 pill carries twelve times the labeled ethinyl estradiol dose.

Why this keeps happening:the price tools file them together. One major coupon site puts Jinteli in the same product menu as Junel 1/20, Junel 1.5/30, Larin, Loestrin and Microgestin, with a strength dropdown that mixes 1 mg/5 mcg and 0.5 mg/2.5 mcg right in among 1 mg/0.02 mg and 1.5 mg/0.03 mg. Drugs.com files the whole ingredient pair under its contraceptives drug class. GoodRx does answer this directly — its femhrt page states plainly that femhrt isn’t used for birth control — but that answer sits in a dropdown at the bottom of the page, not beside the price, which is where the mistake actually gets made.

So here’s how to check. Don’t go by the name. Confirm all four of these:

1. Both active ingredients — norethindrone acetate and ethinyl estradiol
2. The exact strength — 0.5 mg/2.5 mcg or 1 mg/5 mcg
3. The dosage form — oral tablet
4. The tablet count in the pack you’re being quoted

What replaced femhrt, and is it really the same medicine?

Several FDA-approved generic versions contain the same two active ingredients at the same strengths. Lupin describes Fyavolv as the AB-rated generic equivalent of femhrt, approved for moderate to severe menopausal vasomotor symptoms and prevention of postmenopausal osteoporosis. Teva markets Jinteli. Glenmark and Nivagen market unbranded versions. All require a prescription, and none are controlled substances.

AB-ratedis the FDA’s way of saying two products are therapeutically equivalent — same active ingredients, strength, dosage form and route, and the manufacturer has met the FDA’s bioequivalence requirements. AB rating supports substitution at the pharmacy, subject to your prescription, state law, payer rules, product availability, and pharmacy practice.

That does not mean the tablets are literally identical. Inactive ingredients, color, shape, imprint, and packaging differ by manufacturer.

Compiled from each manufacturer’s current FDA prescribing information and product catalog, reviewed August 1, 2026.

This is why your new box looks nothing like your old one.If you took a white D-shaped tablet for years and now you’re holding a blue round one, that’s consistent with an approved generic from a different manufacturer.

But don’t take our word for your specific bottle. Before you take an unfamiliar tablet, ask the pharmacist to confirm the product name, the strength, and the imprint against your prescription. It takes thirty seconds and it’s the right habit every time a pill changes.

It’s still unsettling when it happens without warning. One woman wrote on WebMD’s review page for this drug that she had taken Jinteli for twenty years and that recently “the pharmacy substituted it for Fyavolv.” No heads-up. That reaction is completely reasonable.

The one question to ask about your prescription

Whether you can get the lower-priced version can come down to a detail most people never look at: whether your prescription allows substitution.

A “dispense as written” instruction, or one naming a specific manufacturer, can restrict what the pharmacy is allowed to hand you — even if an approved alternative is on the shelf.

Ask: “Does my prescription, my state’s rules, and my coverage allow you to substitute another approved manufacturer’s version?”

Does a bigger fill cost less?

Often, yes — but it isn’t automatic, and your prescriber has to authorize the quantity. In one ZIP code on August 1, 2026, 84-tablet discount-card totals worked out to $19.53–$38.25 per 28 days. A 90-tablet cash listing came to about $25.83, and a direct-cash 90-tablet medication price came to about $9.53 before shipping.

The cheapest 84-tablet route came in at $19.53 per 28 days — that’s $6.23 less per 28 days than the best single-month card price we found, or about $80.99 across 13 fills covering 364 days. These are two different sources and two different configurations, so treat it as a reason to ask, not a guarantee.

One 84-tablet pickup also replaces three 28-tablet pickups — two fewer trips over that stretch.

⚠️ 84 tablets is not a 90-day supply

This trips people up constantly, and it’s why so many online prices look wrong.

At one tablet daily— the dose the FDA label specifies — the math is simple and unforgiving:

• 28 tablets = 28 days
• 84 tablets = 84 days — six days fewer than a 90-day fill
• 90 tablets = 90 days
• 140 tablets = 140 days (five 28-day cards)

Count tablets, not months.

And if you want a true annual figure: 13 packs of 28 tablets cover 364 days. Twelve packs cover 336 days — 29 days short of a year. So multiply a 28-day price by 13, not 12.

Before you ask for a bigger fill, check:

• Your prescriber has authorized that quantity
• The pharmacy can actually dispense that package size
• Shipping is in your comparison, if it’s mail order
• You can afford the whole total today
• You’re not expecting a medication change soon

What to ask the pharmacist

Copy this. Read it out loud if that’s easier.

1. “Is the price you quoted for 28 tablets, or a larger pack?”
2. “Is that total the plain cash price, an insurance price, or a discount-card price?”
3. “Which manufacturer’s version do you have in stock — Teva, Lupin, Glenmark, or Nivagen — and can you price the others?”
4. “What’s your plain cash price, and what does it come to if you run this discount card?”
5. “Is this the 1 mg/5 mcg or the 0.5 mg/2.5 mcg?”
6. “What’s the largest quantity my prescription authorizes and you can actually dispense — 84, 90, or another count — and what does that work out to per 28 days?”

No arguing, no haggling. You’re asking them to show you numbers they already have.

Where can I fill the current generic?

Any pharmacy that stocks it can fill an FDA-approved generic version with a valid prescription. On August 1, 2026, the lowest published medication-only price we found was at Cost Plus Drugs — $30.63 for 90 tablets of the 1 mg/5 mcg and $29.15 for 90 tablets of the 0.5 mg/2.5 mcg — with shipping and the final checkout total added separately. Stock is not guaranteed anywhere, so confirm before you transfer a prescription.

Your realistic routes:

One honest caveat about the direct-cash route: the published price is for the medication. It is not the delivered total. Add shipping, complete the checkout, and compare thatnumber against your local card price. We didn’t complete a purchase, so we can’t tell you what the final figure is for your address.

Is there a manufacturer coupon or patient assistance program?

We found no current savings program for femhrt, Fyavolv, Jinteli, or the unbranded generics in the official manufacturer and assistance sources we checked on August 1, 2026. Glenmark states on its own website that it has no active copay assistance programs. The original brand is no longer marketed, so there’s no active original-brand savings program to fall back on.

Here’s what kinds of help exist in general, so you can spot the difference:

Discount cards are one route here. So are direct-cash pharmacy prices, a larger authorized quantity, and — where they apply — insurance or Medicare Extra Help.

One honest caveat: proving a negative is harder than proving a positive. We checked the published manufacturer and assistance sources as of August 1, 2026 and found nothing. We did not reach a company representative by phone.

Does insurance, Medicare, or an HSA cover it?

Coverage and tier vary by plan, so your own formulary is the only reliable answer. If you’re on Medicare, you can pay cash with a discount card instead of using your Part D benefit — but that purchase won’t count toward your deductible or your out-of-pocket maximum. Prescription medication is generally an eligible HSA and FSA expense.

If you have commercial insurance:search the generic name — norethindrone acetate and ethinyl estradiol — and also the current marketed names Fyavolv and Jinteli. Formulary naming varies between plans, and searching only a withdrawn brand name may not return what’s actually covered.

If you have Medicare: you’re allowed to skip your Part D benefit and pay cash. Sometimes that’s cheaper. Two things to weigh first:

• In 2026, the Medicare Part D out-of-pocket maximum is $2,100 for covered Part D drugs. Once you reach it, you pay nothing more for those drugs that year. Cash purchases don’t count toward it.
• If you qualify for Extra Help, you’d pay up to $5.10 for a genericprescription. That’s below every cash and discount-card figure verified on this page. Extra Help works inside the Part D benefit, so you’d use your plan, not a coupon.

If you have an HSA or FSA:prescription medication is generally an eligible medical expense. IRS Publication 969 covers the account rules for HSAs and health FSAs; Publication 502 covers what counts as a medical expense. Keep the receipt, and check your plan administrator’s rules.

What if I still can’t get it, or don’t have a prescriber?

If your prescription has run out, your prescriber has retired, or your pharmacy can ’t source any version, you need a clinician before you need a price. What a prescriber can do here is specific: rewrite the prescription for a currently marketed generic, authorize a larger quantity, allow substitution, or choose a different product if supply becomes a problem.

One thing to be clear about, because it changes how you should read everything below: the provider prices in this section are visit and care fees. They are not prices for this medication. Wherever your prescription is sent, the dispensing pharmacy sets the drug price — so ask any service where the prescription goes and what that pharmacy charges.

Before you go looking for a new prescriber, ask your current one three things:

1. “Can you rewrite this for a currently marketed generic?”
2. “Can you write it for a larger quantity — 84 or 90 tablets — if the pharmacy can dispense it?”
3. “If this becomes hard to get, what backup would you want me to ask about?”

Most women never ask the third one. It’s the one that prevents the panic phone call six months from now.

If you don’t have a prescriber, or you can’t get an appointment, a licensed telehealth clinician may be able to evaluate you and prescribe a currently marketed generic, where the service operates in your state and the clinician determines it’s appropriate.

Affiliate disclosure: the two links below are affiliate links. If you sign up, we may earn a commission at no cost to you. It doesn’t change what we’ve written — see our affiliate disclosure.

Two prescriber-access options, and what we could and couldn’t verify

If you’re paying cash and you need someone to look at a straightforward refill, Sesame is the lower-cost entry point of the two on published visit pricing.

If you’d rather run the visit through your insurance, Midi is in network with most PPO plans, so the visit may cost you a copay instead of the full self-pay rate.

What does the current FDA label say?

Approved uses are the same across the marketed generics: treatment of moderate to severe vasomotor symptoms due to menopause, and prevention of postmenopausal osteoporosis, in women with a uterus, at one tablet daily. But each manufacturer maintains its own label with its own revision history — so “the current label” depends on whose product you were given.

The four boxed warning headings on the current Fyavolv label are: cardiovascular disorders, breast cancer, endometrial cancer, and probable dementia.

Why this is worth your attention right now.The FDA began asking manufacturers to update menopausal hormone therapy labeling in November 2025 and approved a first batch of six products in February 2026. Those changes happen product by product, as each is approved. If you’ve seen headlines saying the FDA “removed the warning from hormone therapy,” that’s the announcement — not necessarily the insert in your box. Read the label your product actually carries, and ask your prescriber what it means for you.

A few facts worth knowing:

• It’s not a controlled substance.DEA Schedule: None. It’s prescription-only, but not controlled.
• It’s for women who still have a uterus.The progestin reduces the risk of endometrial hyperplasia — a thickening of the uterine lining that can be a precursor to cancer — which estrogen alone can cause. The label reports hyperplasia occurred in “approximately 1 percent or less” of women taking it.
• Report any vaginal bleeding.The label’s instruction is to tell your healthcare provider “as soon as possible.” There’s no waiting period in that sentence, and we’re not going to invent one.
• Two label-listed interactions you may recognize: combination hormonal products can significantly lower blood levels of lamotrigine, a seizure medication, which may reduce seizure control. And atorvastatinraises ethinyl estradiol levels by about 20%. This is not the complete interaction list — tell your pharmacist everything you take.

About hormone blood tests

The label says plainly, in section 5.17: “Serum follicle stimulating hormone (FSH) and estradiol levels have not been shown to be useful in the management of moderate to severe vasomotor symptoms.”

In plain terms: a blood hormone level isn’t the tool for deciding whether this medication is managing your hot flashes and night sweats. Serum estrogen numbers don’t reliably tell you how an individual woman is responding.

If you’ve been told “your estrogen level looks normal, so you probably don’t need this,” that’s a fair thing to bring back to your prescriber and ask about — specifically, what that result is being used to decide.

Contact a clinician before making a refill or medication decision if you have:

• New or unexplained vaginal bleeding
• A history of breast cancer, blood clots, stroke, or heart attack
• Liver disease
• A known clotting disorder
• Any thought of changing your dose, splitting tablets, or stopping — for cost reasons or any other reason

A price guide can explain how pharmacy billing works. It can’t tell you whether this medicine is right for you.

What we actually verified

You should be able to check our work — and see where it stops.

How we work: this page was produced under The HRT Index Verification Standard— we read every published price, separate FDA-approved from compounded, verify state availability and insurance, and re-check on a fixed schedule. Prices here are re-checked monthly. Regulatory status and labeling are re-checked quarterly, or immediately if the FDA issues something new.

Update log
August 1, 2026 — Initial regulatory, labeling, and price verification.

Frequently asked questions

Is brand-name femhrt still available?

No. Brand-name femhrt is no longer marketed in the U.S. The FDA withdrew approval of NDA 021065 effective October 5, 2023, after the sponsor reported the product was no longer marketed. Pharmacies could dispense remaining inventory until it ran out or expired. FDA-approved generic versions are still marketed.

Why does one website say femhrt costs more than $836?

That listing is for 140 tablets of the no-longer-marketed brand — about $835.59, or roughly $167.12 per 28 days. It's a legacy listing. The generic with a discount card ran $25.76 to $44.52 for 28 tablets on August 1, 2026.

What is the generic name for femhrt?

Norethindrone acetate and ethinyl estradiol. It's marketed as Fyavolv and Jinteli, and as unbranded generics from manufacturers including Glenmark and Nivagen.

Is Jinteli the same as femhrt?

Jinteli is an FDA-approved ANDA product containing norethindrone acetate and ethinyl estradiol in the 1 mg/5 mcg strength, marketed by Teva. Same active ingredients and strength as the brand's higher strength. The tablet looks different — white and round, imprinted B and 125.

Is Fyavolv the same as Jinteli?

Both contain norethindrone acetate and ethinyl estradiol. Lupin describes Fyavolv as the AB-rated generic equivalent of femhrt, meaning the FDA determined it meets bioequivalence requirements. Fyavolv is marketed in both strengths; Jinteli in the 1 mg/5 mcg.

How much is 28 tablets without insurance?

For the 1 mg/5 mcg generic on August 1, 2026: $25.76 to $44.52 with a discount card and $46.20 to $84.56 at retail benchmarks, across four major chains. A 90-tablet direct-cash listing worked out to about $9.53 per 28 days before shipping.

Is 84 tablets a 90-day supply?

No. At one tablet daily — the dose the FDA label specifies — 84 tablets last 84 days, six days fewer than a 90-day fill. Plan by tablet count, not by months.

Can I use GoodRx or SingleCare without insurance?

Yes. Discount cards are designed for cash-paying customers and are free to access at participating pharmacies, subject to each card's terms. They're processed as cash transactions rather than through insurance, so you generally can't combine the two.

Does a coupon purchase count toward my deductible?

Often not, because it's processed as a cash transaction outside your plan. Ask your insurer directly whether a cash purchase can be submitted for credit toward your deductible or out-of-pocket maximum before choosing the coupon route.

Is femhrt birth control?

No. femhrt and its generics are approved for menopausal vasomotor symptoms and prevention of postmenopausal osteoporosis, and contain 5 or 2.5 micrograms of ethinyl estradiol. The contraceptive formulations sharing these ingredients contain 20 or 30 micrograms and are approved to prevent pregnancy.

Is femhrt a controlled substance?

No. The FDA labeling lists DEA Schedule: None. It's a prescription medication, but it isn't a controlled substance.

Can I pick the cheaper strength to save money?

No. The strength is a clinical decision your prescriber made for your situation, not a shopping preference. If cost is a problem, say that to your prescriber directly — there are other levers, including quantity, substitution, and different products.

Will the pharmacy automatically give me a generic?

Not always. It depends on how your prescription was written, your state's substitution rules, your coverage, and what's in stock. A 'dispense as written' instruction can restrict substitution. Ask the pharmacist.

Does the Cost Plus Drugs price include shipping?

No. Cost Plus displays a medication price; shipping and location-based taxes are added at checkout. Compare the final checkout total, not the listed price.

Your next step, depending on where you are

Sources

All checked August 1, 2026 unless the source states its own date.

1. U.S. Food and Drug Administration. Merck Sharp & Dohme LLC, et al.; Withdrawal of Approval of 35 New Drug Applications.Federal Register, Vol. 88, No. 170, pp. 60690–60691. September 5, 2023. Docket No. FDA-2023-N-3549.
2. U.S. Food and Drug Administration. Federal Register determinations that the femhrt reference products were not withdrawn from sale for reasons of safety or effectiveness.
3. DailyMed, U.S. National Library of Medicine. Current prescribing information for Fyavolv (Lupin), Jinteli (Teva), and norethindrone acetate and ethinyl estradiol tablets (Nivagen). Accessed August 1, 2026.
4. DailyMed. FEMHRT — norethindrone acetate/ethinyl estradiol tablet (archived labeling record). Accessed August 1, 2026.
5. Lupin Limited. Lupin Launches Generic Femhrt Tablets in the US. Company press release.
6. Glenmark Pharmaceuticals U.S. Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 0.5 mg/2.5 mcg & 1 mg/5 mcg product catalog, and Copay Assistance Programs page. Accessed August 1, 2026.
7. Mark Cuban Cost Plus Drug Company. Norethindrone acetate–ethinyl estradiol 90-tablet product pages, both strengths. Accessed August 1, 2026.
8. SingleCare. Fyavolv, Jinteli, and norethindrone–ethinyl estradiol price pages. Accessed August 1, 2026.
9. WellRx. Fyavolv and Jinteli price pages, ZIP 77381. Accessed August 1, 2026.
10. Drugs.com. femhrt and Jinteli price guides; generic femhrt availability page. Accessed August 1, 2026.
11. Honeybee Health. Norethindrone + ethinyl estradiol product page. Accessed August 1, 2026.
12. Medicare.gov. 2026 Part D drug costs and Extra Help.
13. Internal Revenue Service. Publication 969, Health Savings Accounts and Other Tax-Favored Health Plans; Publication 502, Medical and Dental Expenses.

Prices change. Everything above was captured on the date shown and is re-checked monthly.

Educational information only — not medical advice, and not a substitute for your clinician or pharmacist. Prices are dated snapshots from published sources, not guaranteed quotes; confirm with your pharmacy before you fill. We re-verify pricing on this page monthly and the full page quarterly. Found something wrong? Tell us— we publish corrections.

Last updated: August 2, 2026. Last verified: August 1, 2026.

Sources: Federal Register Vol. 88, No. 170 (Docket FDA-2023-N-3549); DailyMed prescribing information for Fyavolv, Jinteli, and Nivagen generics; Glenmark Pharmaceuticals U.S.; Cost Plus Drugs; SingleCare; WellRx; Drugs.com; Honeybee Health; Medicare.gov; IRS Publications 969 and 502. All captured August 1, 2026.